Wilson Deborah V, Evans A Thomas, Carpenter Rachael A, Mullineaux David R
Department of Large Animal Clinical Sciences, Michigan State University, East Lansing, MI 48824, USA.
Vet Anaesth Analg. 2004 Apr;31(2):102-8. doi: 10.1111/j.1467-2987.2004.00152.x.
To characterize the effects of four anesthetic protocols on the size of the spleen during surgery in dogs.
Prospective experimental trial.
Twenty-four beagle dogs, 1.1 +/- 0.3 years of age and weighing 10.9 +/- 2.7 kg.
Dogs were allocated to receive one of four anesthetic protocols: 1 - pre-medication with acepromazine and butorphanol, induction with thiopental; 2 - pre-medication with acepromazine and butorphanol, induction with propofol; 3 - pre-medication with medetomidine and butorphanol, induction with propofol; and 4 - pre-medication with medetomidine and butorphanol, induction with ketamine and diazepam. Anesthesia was then maintained with halothane. At laparotomy, the spleen length, width, and height were measured, these were measured again just prior to closure of the abdomen. Splenic area and volume were calculated. Hematocrit and total serum protein (TSP) were measured before and after induction and during laparotomy.
Splenic volume was greatest after protocol 4 (161.2 +/- 40.2 cm(3); p < 0.05) and was least after protocol 2. The differences in volume were because of differences in length, width, and height between groups. There was no significant change in area, length, or width over the study period. Hematocrit decreased significantly in all dogs but at different times. The decrease occurred after pre-medication if acepromazine was administered, at induction following protocol 3 and during surgery following protocol 4.
If splenic volume is to be minimized during surgery, then acepromazine and propofol should be used in the anesthetic protocol. The administration of medetomidine, diazepam, and ketamine will produce a greater splenic volume. Lack of correlation between hematocrit and spleen size following the anesthetic protocols studied suggests sequestration of red blood cells in nonsplenic sites.
描述四种麻醉方案对犬类手术期间脾脏大小的影响。
前瞻性实验性试验。
24只比格犬,年龄1.1±0.3岁,体重10.9±2.7千克。
将犬分配接受四种麻醉方案之一:1 - 用乙酰丙嗪和布托啡诺进行术前用药,硫喷妥钠诱导;2 - 用乙酰丙嗪和布托啡诺进行术前用药,丙泊酚诱导;3 - 用美托咪定和布托啡诺进行术前用药,丙泊酚诱导;4 - 用美托咪定和布托啡诺进行术前用药,氯胺酮和地西泮诱导。然后用氟烷维持麻醉。在剖腹术时,测量脾脏的长度、宽度和高度,在腹部关闭前再次测量。计算脾脏面积和体积。在诱导前、诱导后和剖腹术期间测量血细胞比容和总血清蛋白(TSP)。
方案4后脾脏体积最大(161.2±40.2立方厘米;p<0.05),方案2后最小。体积差异是由于组间长度、宽度和高度的差异。在研究期间,面积、长度或宽度没有显著变化。所有犬的血细胞比容均显著下降,但时间不同。如果给予乙酰丙嗪,在术前用药后下降;方案3诱导后下降;方案4手术期间下降。
如果要在手术期间使脾脏体积最小化,那么麻醉方案中应使用乙酰丙嗪和丙泊酚。给予美托咪定、地西泮和氯胺酮会使脾脏体积更大。在所研究的麻醉方案后,血细胞比容与脾脏大小之间缺乏相关性,提示红细胞在非脾脏部位的滞留。